(CDNA) CareDx - Performance 23.9% in 12m
CDNA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-50.99%
#71 in Peer-Group
Rel. Strength
70.21%
#2287 in Stock-Universe
Total Return 12m
23.89%
#48 in Peer-Group
Total Return 5y
-44.22%
#57 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 17.2 |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 33.99 USD |
| 52 Week Low | 14.18 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 63.66 |
| Buy/Sell Signal +-5 | -0.59 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CDNA (23.9%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CDNA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CDNA
| Total Return (including Dividends) | CDNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -0.31% | 3.36% | 5.25% |
| 3 Months | 11.34% | 15.73% | 24.13% |
| 12 Months | 23.89% | -7.02% | 14.15% |
| 5 Years | -44.22% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | CDNA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.2% | 4.4% | 81% |
| 3 Months | 48.9% | 78.8% | 96.9% |
| 12 Months | -55.1% | -85.8% | 44.9% |
| 5 Years | -65.1% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th50.50 | -3.55% | -5.28% |
| 3 Month | %th44.50 | -3.79% | -10.30% |
| 12 Month | %th77.00 | 33.25% | 8.53% |
| 5 Years | %th72.50 | -26.40% | -73.67% |
FAQs
Does CareDx (CDNA) outperform the market?
Yes,
over the last 12 months CDNA made 23.89%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months CDNA made 11.34%, while XBI made 15.73%.
Performance Comparison CDNA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CDNA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.7% | -5.6% | -23.2% | 10% |
| US NASDAQ 100 | QQQ | -1.4% | -5.6% | -23.9% | 11% |
| German DAX 40 | DAX | 0.5% | 1.1% | -35.4% | -5% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -1.5% | -3.6% | -26.7% | 4% |
| Hongkong Hang Seng | HSI | -1.3% | -6.4% | -42.7% | -15% |
| India NIFTY 50 | INDA | 0.2% | -3.8% | -23.6% | 25% |
| Brasil Bovespa | EWZ | -4.1% | -9.1% | -48.3% | 14% |
CDNA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -0.3% | -6.2% | -27.4% | -1% |
| Consumer Discretionary | XLY | -1.2% | -3.5% | -15.6% | 6% |
| Consumer Staples | XLP | -2% | -1% | -24.9% | 15% |
| Energy | XLE | -2% | -7.4% | -19.1% | 24% |
| Financial | XLF | -2.4% | -5.4% | -28.2% | -6% |
| Health Care | XLV | -1.1% | -2.5% | -15.9% | 28% |
| Industrial | XLI | -1.7% | -4.5% | -31.1% | -1% |
| Materials | XLB | -3.9% | -4.6% | -27.8% | 18% |
| Real Estate | XLRE | -1.6% | -1.3% | -23% | 11% |
| Technology | XLK | -2.4% | -9% | -25.6% | 13% |
| Utilities | XLU | -0.6% | -2.1% | -26.5% | 1% |
| Aerospace & Defense | XAR | 0.5% | -7.4% | -41.8% | -25% |
| Biotech | XBI | -2.6% | -3.7% | -10% | 31% |
| Homebuilder | XHB | -4.2% | -7.3% | -16.1% | 18% |
| Retail | XRT | -4.2% | -5.3% | -18.9% | 13% |
CDNA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -2.6% | -8.75% | -14.8% | 31% |
| Natural Gas | UNG | 7.9% | 9.5% | -6.4% | 26% |
| Gold | GLD | -1.9% | 0.9% | -43.9% | -15% |
| Silver | SLV | -2.7% | -7.2% | -40.6% | 6% |
| Copper | CPER | -0.7% | -4.9% | -40.3% | 13% |
CDNA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.2% | -1.4% | -19.8% | 26% |
| iShares High Yield Corp. Bond | HYG | -0.5% | -1.9% | -22.1% | 14% |